PI3KAD-Deg-5 |
PI3KAD-Deg-5 : Degrader (PROTAC) of PIK3CA, PIK3CD
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PIK3CA |
|
|
| PIK3CD |
|
Degrader (PROTAC)
up to 100 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Whole-proteome analysis demonstrated that PI3Kα was significantly degraded by D5 in T47D cells, but ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
>10,000-fold degradation selectivity over the PI3Kβ and PI3Kγ isoforms
Potency Cellular
In Vitro
PIK3CA
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c03368
PIK3CD
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c03368
In Vivo Validations
Rat
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
4.43 h
Systemic clearance:
1.99 L/h/Kg
Cmax:
4612.84 ng/mL
Area Under the Curve::
510.26 h*ng/mL
DOI Reference: 10.1021/acs.jmedchem.5c03368
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
1.66 h
Systemic clearance:
108.80 L/h/Kg
Cmax:
17.30 ng/mL
Tmax:
1.44 h
Area Under the Curve::
94.26 h*ng/mL
Bioavailability:
1.85%
DOI Reference: 10.1021/acs.jmedchem.5c03368
Negative Control Compounds
D5Me
Notes: D5Me not degraded the PI3Kα protein
SMILES:
COC1=C2C(C3=NCCN3C(NC(C4=CN=C(N)N=C4)=O)=N2)=CC=C1OCCCN5CCN(CCCCCCCC(NC6=C(C(N(C7CCC(N(C)C7=O)=O)C8)=O)C8=CC=C6)=O)CC5
Chemical Information
Coming Soon...